Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 2;9(4):861.
doi: 10.3390/cells9040861.

The Emerging Roles of Exosomes as EMT Regulators in Cancer

Affiliations
Review

The Emerging Roles of Exosomes as EMT Regulators in Cancer

Hyunwoo Kim et al. Cells. .

Abstract

Epithelial-mesenchymal transition (EMT) causes epithelial cells to lose their polarity and adhesion property, and endows them with migratory and invasive properties to enable them to become mesenchymal stem cells. EMT occurs throughout embryonic development, during wound healing, and in various pathological processes, including tumor progression. Considerable research in the last few decades has revealed that EMT is invariably related to tumor aggressiveness and metastasis. Apart from the interactions between numerous intracellular signaling pathways known to regulate EMT, extracellular modulators in the tumor microenvironment also influence tumor cells to undergo EMT, with extracellular vesicles (EVs) receiving increasing attention as EMT inducers. EVs comprise exosomes and microvesicles that carry proteins, nucleic acids, lipids, and other small molecules to stimulate EMT in cells. Among EVs, exosomes have been investigated in many studies, and their role has been found to be significant with respect to regulating intercellular communications. In this review, we summarize recent studies on exosomes and their cargoes that induce cancer-associated EMT. Furthermore, we describe the possible applications of exosomes as promising therapeutic strategies.

Keywords: Cancer; Epithelial mesenchymal transition; Exosome; Hippo pathway; Wnt/β-catenin pathway.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Schematic representation of exosomes. Exosomes are generated from multivesicular endosome (MVE), loaded with cellular components in donor cells, and secreted to the extracellular environment. Exosomes transfer proteins, nucleic acids, metabolites, and even organelles to recipient cells in both autocrinal and paracrinal manners. The uptake of exosomes is mediated by receptor activation, endocytosis, and membrane fusion.
Figure 2
Figure 2
Comprehensive schematic diagram of signaling pathways related to exosome-induced EMT in cancer. The principal signaling pathways and transcription factors involved in exosome-mediated EMT induction are depicted.
Figure 3
Figure 3
Schematic representation of exosome-induced EMT in cancer. The involvement of EMT-related signaling pathways during exosome-mediated EMT is depicted. The blue triangle indicates activation and red inverted triangle indicates inactivation of the signal.

Similar articles

Cited by

References

    1. Pastushenko I., Blanpain C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2019;29:212–226. doi: 10.1016/j.tcb.2018.12.001. - DOI - PubMed
    1. Zhang Y., Weinberg R.A. Epithelial-to-mesenchymal transition in cancer: Complexity and opportunities. Front. Med. 2018;12:361–373. doi: 10.1007/s11684-018-0656-6. - DOI - PMC - PubMed
    1. Zhou P., Li B., Liu F., Zhang M., Wang Q., Liu Y., Yao Y., Li D. The epithelial to mesenchymal transition (EMT) and cancer stem cells: Implication for treatment resistance in pancreatic cancer. Mol. Cancer. 2017;16:52. doi: 10.1186/s12943-017-0624-9. - DOI - PMC - PubMed
    1. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene. 2010;29:4741–4751. doi: 10.1038/onc.2010.215. - DOI - PMC - PubMed
    1. Azmi A.S. Unveiling the role of nuclear transport in epithelial-to-mesenchymal transition. Curr. Cancer Drug Targets. 2013;13:906–914. doi: 10.2174/15680096113136660096. - DOI - PubMed

Publication types